During the past decade, Westside Medical Associates of Los Angeles conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 8 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 6 clinical trials were completed. i.e. 54.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Westside Medical Associates of Los Angeles" #1 sponsor was "Amgen" with 3 trials, followed by "Arrowhead Pharmaceuticals" with 3 trials sponsored, "NeuroBo Pharmaceuticals Inc." with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "Westside Medical Associates of Los Angeles" with 3 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Westside Medical Associates of Los Angeles" #1 collaborator was "Bill and Melinda Gates Foundation" with 1 trials as a collaborator, "DACIMA Software" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Westside Medical Associates of Los Angeles" are "Cardiovascular Disease" (3 trials), "Atherosclerotic Cardiovascular Disease" (2 trials), "Heart Failure" (2 trials), "Hypercholesteremia" (2 trials) and "Severe Hypertriglyceridemia" (2 trials). Many other conditions were trialed in "Westside Medical Associates of Los Angeles" in a lesser frequency.

Most popular intervention types in "Westside Medical Associates of Los Angeles" are "Drug" (19 trials), "Other" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "ARO-APOC3" (3 trials), "Gemcabene" (3 trials), "bococizumab (PF-04950615)" (2 trials) and "ASA 100 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Westside Medical Associates of Los Angeles" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Westside Medical Associates of Los Angeles". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 7 completed trials in Westside Medical Associates of Los Angeles, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Westside Medical Associates of Los Angeles, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".